These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 23165110

  • 21. Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases.
    Rashikh A, Ahmad SJ, Pillai KK, Najmi AK.
    J Pharm Pharmacol; 2012 Apr; 64(4):470-81. PubMed ID: 22420653
    [Abstract] [Full Text] [Related]

  • 22. [Hypertension as a function of age].
    Gensini GF, Corradi F.
    Ital Heart J; 2000 Jun; 1 Suppl 2():23-31. PubMed ID: 10905125
    [Abstract] [Full Text] [Related]

  • 23. [Influence of blood pressure variability during office visit on the estimation of blood pressure control in treated hypertensive patients].
    Villeneuve F, Rosenbaum D, Gury C, Girerd X.
    Ann Cardiol Angeiol (Paris); 2012 Jun; 61(3):198-202. PubMed ID: 22677179
    [Abstract] [Full Text] [Related]

  • 24. Office and ambulatory pulse pressure--association with clinical characteristics and cardiovascular risk factors in normoalbuminuric patients with type 2 diabetes (ROADMAP study).
    Januszewicz A, Ritz E, Viberti G, Mimran A, Rabelink AJ, Rump LC, Ruilope LM, Katayama S, Ito S, Izzo JL, Haller H.
    J Hum Hypertens; 2011 Nov; 25(11):679-85. PubMed ID: 21150933
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B, Brilla C, Kruse T, Noll B, Bethge C.
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [Abstract] [Full Text] [Related]

  • 28. Retrospective and prospective research on hypertension-related end-organ damage.
    Perloff D.
    J Cardiovasc Pharmacol; 1994 Dec; 24 Suppl A():S1-5. PubMed ID: 7603071
    [Abstract] [Full Text] [Related]

  • 29. Blood pressure variability in chronic kidney disease patients.
    Mallamaci F, Tripepi G.
    Blood Purif; 2013 Dec; 36(1):58-62. PubMed ID: 23735729
    [Abstract] [Full Text] [Related]

  • 30. Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program.
    Kostis JB, Sedjro JE, Cabrera J, Cosgrove NM, Pantazopoulos JS, Kostis WJ, Pressel SL, Davis BR.
    J Clin Hypertens (Greenwich); 2014 Jan; 16(1):34-40. PubMed ID: 24325609
    [Abstract] [Full Text] [Related]

  • 31. Protocol for prospective collaborative overviews of major randomized trials of blood-pressure-lowering treatments. World Health Organization-International Society of Hypertension Blood Pressure Lowering Treatment Trialists' Collaboration.
    J Hypertens; 1998 Feb; 16(2):127-37. PubMed ID: 9535138
    [Abstract] [Full Text] [Related]

  • 32. [Difference in blood pressure measured in the office and out of office].
    Kuwajima I.
    Nihon Rinsho; 2008 Aug; 66(8):1531-6. PubMed ID: 18700553
    [Abstract] [Full Text] [Related]

  • 33. [Visit-to-visit variability: Prognostic significance?].
    Ly C, Agnoletti D, Safar M, Blacher J.
    Presse Med; 2012 Jun; 41(6 Pt 1):650-4. PubMed ID: 22498102
    [Abstract] [Full Text] [Related]

  • 34. Prognostic factors in resistant hypertension: implications for cardiovascular risk stratification and therapeutic management.
    de Souza F, Muxfeldt ES, Salles GF.
    Expert Rev Cardiovasc Ther; 2012 Jun; 10(6):735-45. PubMed ID: 22894630
    [Abstract] [Full Text] [Related]

  • 35. Does treatment of non-malignant hypertension reduce the incidence of renal dysfunction? A meta-analysis of 10 randomised, controlled trials.
    Hsu CY.
    J Hum Hypertens; 2001 Feb; 15(2):99-106. PubMed ID: 11317188
    [Abstract] [Full Text] [Related]

  • 36. Hypertension in the elderly and the very old.
    Casiglia E, Tikhonoff V, Pessina AC.
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):659-65. PubMed ID: 19505281
    [Abstract] [Full Text] [Related]

  • 37. [Are all antihypertensive drugs renoprotective?].
    Wolf S, Risler T.
    Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
    [Abstract] [Full Text] [Related]

  • 38. [Renal and cardiovascular protection associated to antihypertensive treatment in the elderly].
    Luño J, García de Vinuesa S.
    Nefrologia; 2002 May; 22 Suppl 1():30-5. PubMed ID: 11987668
    [Abstract] [Full Text] [Related]

  • 39. [Guidelines 2007 of the European Societies of Hypertension and of Cardiology: what has changed?].
    Schmieder RE.
    Dtsch Med Wochenschr; 2007 Nov; 132(46):2463-6. PubMed ID: 17987556
    [No Abstract] [Full Text] [Related]

  • 40. [White coat hypertension].
    Umei H, Matsuoka H, Imaizumi T.
    Nihon Rinsho; 2006 Aug; 64 Suppl 6():68-72. PubMed ID: 16981522
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.